Case Study: IM Associates Achieves Confidential Pharma Benchmarking with Decentriq

First ever large scale benchmarking among pharmaceuticals without anyone seeing the raw data

IM Associates, a healthcare-focused data insights and consulting firm, runs an annual benchmarking study with 20 pharmaceutical companies. Their traditional process relied on a third party to anonymize sensitive participant data before analysis, which created friction, slowed onboarding, increased privacy concerns, and made it harder to maintain trust and agility.

To solve this, IM Associates used Decentriq’s data clean rooms, powered by confidential computing, to run the benchmarking study without anyone accessing the raw data. With Decentriq, IM Associates could define permissions, invite participants to inspect the analysis, securely run checks and analysis on encrypted data, and deliver individual reports. The result was faster, more flexible benchmarking, stronger confidentiality, and greater participation—while ensuring that neither IM Associates, Decentriq, nor the cloud provider could see the sensitive data.

IM Associates

Bart Bierinckx

Chief Executive Officer